These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6506247)

  • 1. [Cyclic mastalgia and prolactin stimulating drugs. A case-control study].
    Watt-Boolsen S; Jørgensen J
    Ugeskr Laeger; 1984 May; 146(21):1568-9. PubMed ID: 6506247
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum prolactin and oestradiol levels in women with cyclical mastalgia.
    Watt-Boolsen S; Andersen AN; Blichert-Toft M
    Horm Metab Res; 1981 Dec; 13(12):700-2. PubMed ID: 7319468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin response to dopamine synthesis inhibition using monoiodotyrosine in subjects on oral contraceptives and patients with pathological hyperprolactinemia.
    Ho KY; Smythe GA; Lazarus L
    J Clin Endocrinol Metab; 1983 Apr; 56(4):692-6. PubMed ID: 6833458
    [No Abstract]   [Full Text] [Related]  

  • 4. Membrane action of tricyclic drugs. Spectroscopic studies of a series of phenothiazines compared with tricyclic antidepressive substances in red cell membrane, using the spin labelling technique.
    Zimmer G; Schulze P
    Arzneimittelforschung; 1981; 31(9):1389-92. PubMed ID: 6272818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight gain from combined phenothiazine and tricyclic therapy.
    Pfister AK
    JAMA; 1978 May; 239(19):1959. PubMed ID: 642127
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination therapy in hypertension.
    Simpson FO
    Drugs; 1980 Jul; 20(1):69-73. PubMed ID: 6156815
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical pharmacology of hormonal contraceptives].
    Hubinont PO; Degueldre M; Delvoye P; L'Hermite M; Robyn C; Vekemans M
    Bull Mem Acad R Med Belg; 1975; 130(7-9):351-67. PubMed ID: 800347
    [No Abstract]   [Full Text] [Related]  

  • 8. [Normal and abnormal secretion dynamics of prolactin in the fields of gynecology and obstetrics].
    Ebara Y; Yen SS
    Horumon To Rinsho; 1974 Mar; 22(3):352-60. PubMed ID: 4601238
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.
    Cooper GS; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS
    Arthritis Rheum; 2002 Jul; 46(7):1830-9. PubMed ID: 12124867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New preparations: fluorasizine].
    Farmatsiia; 1976; 25(2):87-9. PubMed ID: 1269798
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased risk for cancer of the breast due to previous medication.
    de Levin RW; Puig OR; Levin E
    Arch Geschwulstforsch; 1984; 54(2):153-8. PubMed ID: 6732438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of prolactin secretion on human lactation.
    Tyson JE; Khojandi M; Huth J; Andreassen B
    J Clin Endocrinol Metab; 1975 May; 40(5):764-73. PubMed ID: 805159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and vitamin B6 metabolism.
    Aly HE; Donald EA; Simpson MH
    Am J Clin Nutr; 1971 Mar; 24(3):297-303. PubMed ID: 5548735
    [No Abstract]   [Full Text] [Related]  

  • 14. Sequential study of plasma euglobulin fibrinolytic activity during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
    Jespersen J
    Gynecol Obstet Invest; 1983; 15(5):266-74. PubMed ID: 6852646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pill and the breast.
    Leis HP
    N Y State J Med; 1970 Dec; 70(23):2911-8. PubMed ID: 4920508
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gonadotropin releasing factor].
    Igarashi M
    Horumon To Rinsho; 1972 Jun; 20(6):427-31. PubMed ID: 4562912
    [No Abstract]   [Full Text] [Related]  

  • 17. [Post-pill amenorrhea and prolactin].
    Volpe A; Baviera G; Montanari GD
    Riv Ital Ginecol; 1977; 58(4):247-52. PubMed ID: 756597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychoactive drugs and brain neurochemical transmitters.
    Valzelli L
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:221+. PubMed ID: 4342945
    [No Abstract]   [Full Text] [Related]  

  • 19. [Growth hormone during oral contraceptive treatment].
    Steiner H
    Schweiz Med Wochenschr; 1969 Jul; 99(31):1115-8. PubMed ID: 4944955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of oral contraceptive agents--a symposium. Action and efficacy of systemic contraceptive agents, and introduction of complications.
    Swerdloff RS
    West J Med; 1975 Jan; 122(1):20-6. PubMed ID: 1089002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.